05-Oct-16 Chinese conglomerate Fosun International is in advanced talks to acquire Hospital da Bahia, a Brazilian hospital in the city of Salvador, for about BRL1 bn (USD308 mn). Brazilian business daily Valor Economico reported that Fosun is also looking to spend an additional BRL2 bn on other acquisitions to form a Brazilian hospital chain. [image: Fosun International Ltd]

03-Oct-16 Intuitive Surgical is expanding into robotic-assisted catheter-based medical devices through a JV with Shanghai Fosun Pharmaceutical. These devices will use IP from Intuitive Surgical and will focus on diagnosis and treatment of lung cancer. R&D and manufacturing will take place in Shanghai. Intuitive Surgical will oversee distribution outside China while the JV will be in charge within China. [image: Asian Scientist Magazine]

02-Oct-16 A pioneering Singapore fertility expert will head efforts to help Chinese women who find it hard to conceive, by setting up medical centres in China. They set up their first in Xiamen two years ago, and will open a centre in Chengdu by Dec-15. "We hope to expand into a network of 600 satellite women's clinics," said CEO Ms Bi. [image: Chew Seng Kim / ST]

01-Oct-16 A Chinese government investigation has revealed that more than 80% of the data used in clinical trials of new drugs have been "fabricated". The investigation, led by the SFDA, looked at data from 1,622 clinical trials. The SFDA found that the suspect data failed to meet analysis requirements, were incomplete, or totally non-existent. [image: Plavevski / Shutterstock / Science Alert]

GGM's 2016 China and Asia-Pacific Ophthalmology market intelligence program subscriptions are now available, giving you access to accurate market data, reliable buyer insights and private custom research topics. Covering Ophthalmology Equipment, IOLs and Hospital Services, the service includes country level data and analysis on: Market opportunities, competitive gaps, surgeon perceptions, installed base, usage, market volume and value size, prices, detailed segmentation, regulations and reimbursement, market players, future outlook, positioning recommendations and more.